Skip to main content
. 2020 Aug 17;2020:3934769. doi: 10.1155/2020/3934769

Figure 6.

Figure 6

Schematic diagram of the mechanism by which MCL attenuates the inflammatory response of NRK-52E cells. MCL inhibits the activation of the NF-κB pathway and NLRP3 inflammasome by inhibiting the release of mROS, thereby ameliorating tubular inflammation.